La thérapie assistée par IA de Recursion Pharma réduit la croissance des polypes dans un essai sur une maladie rare
La thérapie assistée par IA de Recursion Pharma réduit la croissance des polypes dans un essai sur une maladie rare
5 months ago
zonebourse.com
Open Positions
Open Positions
Mar 1, 2024
recursion.com
Careers at Recursion: Join Our Mission | Recursion
Careers at Recursion: Join Our Mission | Recursion
Jan 28, 2021
recursion.com
Recursion Pharma rises, Intel & Five Below fall: Trending Tickers
4:23
Recursion Pharma rises, Intel & Five Below fall: Trending Tickers
Apr 11, 2025
Yahoo
Lightning Round: Recursion Pharma is now a meme stock, says Jim Cramer
5:11
Lightning Round: Recursion Pharma is now a meme stock, says Jim Cramer
6 months ago
MSNCNBC
Silicon Slopes: Chris Gibson, Co-Founder & CEO, Recursion Pharma
Silicon Slopes: Chris Gibson, Co-Founder & CEO, Recursion Pharma
Jan 31, 2020
nasdaq.com
Recursion | LinkedIn
Recursion | LinkedIn
Jul 26, 2024
linkedin.com
0:24
Recursion CEO and President Najat Khan says the AI drug discovery industry is entering a new phase. “It’s no longer about what models you build or about what collaborations you sign,” she says. “It’s about what you unlock that can actually drive better medicines, and Recursion is firmly pioneering that new phase.” #TechBio #finance #earnings #AI #drugdiscovery | Recursion Pharmaceuticals
16.5K views2 months ago
FacebookRecursion Pharmaceuticals
0:58
Jensen Huang at Recursion: Enabling Leaders in AI Drug Discovery In a conversation with Recursion co-founder and CEO Chris Gibson, @nvidia president, co-founder and CEO Jensen Huang says there’s no harder problem than doing “drug discovery in silico” but it’s a problem that’s solvable in this lifetime. To solve it requires 3 key ingredients, Jensen says: 1) the algorithm 2) computing 3) methodology - “which in a large scale is kind of domain expertise” “We could contribute to two of those three
485.3K views8 months ago
FacebookRecursion Pharmaceuticals
1:30
🚀 Recursion has been laying the foundation for a virtual cell from day one – including massive-scale, proprietary biological and chemical datasets, AI models, and one of the industry’s most powerful supercomputers. 💥 In a new video and article we share our progress – and where we’re headed next: ▪️ It started with creating a proprietary data moat, generating and aggregating more than 65 petabytes of multimodal and fit-for-purpose data. ▪️ Then we built a system of interconnected AI models capa
61 views5 months ago
FacebookRecursion Pharmaceuticals
Morgan Stanley Raises Price Target on Recursion Pharmaceuticals to $5 From $4.80, Keeps Equalweight Rating
5 months ago
marketscreener.com
Recursion Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
2 months ago
marketscreener.com
0:04
Inside the AI transformation of drug discovery. On Oct. 15 on the Main Stage of @gitex_global at the Dubai World Trade Center, Recursion cofounder and CEO Chris Gibson will give a keynote on “AI, Data & DNA: TechBio’s Disruption of Drug Discovery” – sharing the inside story of how Recursion’s AI native approach to generating data, automating experiments, and using machine learning to make unbiased discoveries has led, more than a decade later, to TechBio’s leading end-to-end drug discovery and d
119 views7 months ago
FacebookRecursion Pharmaceuticals
0:33
Today we announced positive Phase 2 results from our ongoing TUPELO trial evaluating REC-4881 in patients with familial adenomatous polyposis (FAP) – a rare, inherited disease with no approved pharmacologic treatments. Treatment with REC-4881 demonstrated rapid and durable reductions in polyp burden in the study, with a median 43% reduction in total polyp burden (n=12) after 12 weeks of treatment. 82% of evaluable patients (9 of 11) maintained reductions at Week 25—12 weeks after stopping therap
78 views5 months ago
FacebookRecursion Pharmaceuticals
3:59
'We look like what the future of all biopharma companies will look like', says Recursion CEO Gibson
Aug 8, 2023
CNBC
1:01
AI Drug Discovery Explained: Recursion
4 views1 month ago
YouTubeEric
2:58
5 AI Stocks That Could Make You Rich This Year
1 month ago
YouTubeAlphaSignal
3:35
AI is Designing Drugs in 10 Months. (The Agentic Pharma Revolution)
22 views1 month ago
YouTubeStock Basics Insiders
0:20
Recursion on Instagram: "At JPM, Recursion CEO and President Najat Khan, PhD spoke with Brad Loncar of BiotechTV about her vision for the company, Recursion’s competitive advantages, and the pipeline programs providing the clinical proof points for our platform’s novel insights. 🔹 Some highlights: ▪️ How do you want people to think about Recursion going forward? “Fundamentally, Recursion is here to build differentiated medicines at scale for patients who are waiting. How we do it is different.
3.1K views3 months ago
Instagramrecursionpharma
11:12
Recursion in C
1.1M viewsDec 12, 2018
YouTubeNeso Academy
8:45
Python: RECURSION Explained
316.7K viewsNov 27, 2017
YouTubeProgramming and Math Tutorials
Recursion
Nov 23, 2021
biospace.com
Recursion Pharmaceuticals | Customer Success | Splunk
Nov 7, 2017
splunk.com
32:41
Recursion Tree Method
245.4K viewsJun 20, 2020
YouTubeDr. Hasan Jamal
48:22
6. Recursion and Dictionaries
404.5K viewsFeb 15, 2017
YouTubeMIT OpenCourseWare
12:32
Programming Loops vs Recursion - Computerphile
1.6M viewsSep 22, 2017
YouTubeComputerphile
2:54
Recursive Formulas For Sequences
549.1K viewsFeb 5, 2018
YouTubeThe Organic Chemistry Tutor
5:43
#40 Python Tutorial for Beginners | Recursion
695.4K viewsAug 3, 2018
YouTubeTelusko
1:51:36
Recursion in Programming - Full Course
1.1M viewsJul 19, 2021
YouTubefreeCodeCamp.org
11:12
Solving Linear Recurrence Relations 1
195.2K viewsJan 2, 2014
YouTubeJason Pallett
See more